Altered eosinophil profile in mice with ST6Gal-1 deficiency: an additional role for ST6Gal-1 generated by the P1 promoter in regulating allergic inflammation
- PMID: 20007243
- PMCID: PMC2830128
- DOI: 10.1189/jlb.1108704
Altered eosinophil profile in mice with ST6Gal-1 deficiency: an additional role for ST6Gal-1 generated by the P1 promoter in regulating allergic inflammation
Abstract
Cumulative evidence indicates that the sialyltransferase ST6Gal-1 and the sialyl-glycans, which it constructs, are functionally pleiotropic. Expression of the ST6Gal-1 gene is mediated by six distinct promoter/regulatory regions, and we hypothesized that these promoters may be used differentially to produce ST6Gal-1 for different biologic purposes. To examine this hypothesis, we compared a mouse with a complete deficiency in ST6Gal-1 (Siat1 null) with another mouse that we have created previously with a disruption only in the P1 promoter (Siat1DeltaP1). We noted previously greater neutrophilic inflammation associated with ST6Gal-1 deficiency. Here, we report that ST6Gal-1-deficient mice also have significantly elevated eosinophilic responses. Upon i.p. thioglycollate elicitation, eosinophils accounted for over 20% of the total peritoneal inflammatory cell pool in ST6Gal-1-deficient animals, which was threefold greater than in corresponding wild-type animals. A principal feature of allergic respiratory inflammation is pulmonary eosinophilia, we evaluated the role of ST6Gal-1 in allergic lung inflammation. Using OVA and ABPA experimental models of allergic airways, we showed that ST6Gal-1 deficiency led to greater airway inflammation characterized by excessive airway eosinophilia. The severity of airway inflammation was similar between Siat1DeltaP1 and Siat1 null mice, indicating a role for P1-generated ST6Gal-1 in regulating eosinophilic inflammation. Colony-forming assays suggested greater IL-5-dependent eosinophil progenitor numbers in the marrow of ST6Gal-1-deficient animals. Moreover, allergen provocation of wild-type mice led to a significant reduction in P1-mediated ST6Gal-1 mRNA and accompanied decline in circulatory ST6Gal-1 levels. Taken together, the data implicate ST6Gal-1 as a participant in regulating not only Th1 but also Th2 responses, and ST6Gal-1 deficiency can lead to the development of more severe allergic inflammation with excessive eosinophil production.
Figures
Similar articles
-
Biologic contribution of P1 promoter-mediated expression of ST6Gal I sialyltransferase.Glycobiology. 2003 Aug;13(8):591-600. doi: 10.1093/glycob/cwg066. Epub 2003 Apr 2. Glycobiology. 2003. PMID: 12672700
-
Altered granulopoietic profile and exaggerated acute neutrophilic inflammation in mice with targeted deficiency in the sialyltransferase ST6Gal I.Blood. 2006 Nov 15;108(10):3397-405. doi: 10.1182/blood-2006-04-014779. Epub 2006 Jul 18. Blood. 2006. PMID: 16849643 Free PMC article.
-
Mice deficient in the St3gal3 gene product α2,3 sialyltransferase (ST3Gal-III) exhibit enhanced allergic eosinophilic airway inflammation.J Allergy Clin Immunol. 2014 Jan;133(1):240-7.e1-3. doi: 10.1016/j.jaci.2013.05.018. Epub 2013 Jul 2. J Allergy Clin Immunol. 2014. PMID: 23830412 Free PMC article.
-
Anti-inflammatory IgG production requires functional P1 promoter in β-galactoside α2,6-sialyltransferase 1 (ST6Gal-1) gene.J Biol Chem. 2012 May 4;287(19):15365-70. doi: 10.1074/jbc.M112.345710. Epub 2012 Mar 15. J Biol Chem. 2012. PMID: 22427662 Free PMC article.
-
p110γ/δ Double-Deficiency Induces Eosinophilia and IgE Production but Protects from OVA-Induced Airway Inflammation.PLoS One. 2016 Jul 21;11(7):e0159310. doi: 10.1371/journal.pone.0159310. eCollection 2016. PLoS One. 2016. PMID: 27442134 Free PMC article.
Cited by
-
Role for hepatic and circulatory ST6Gal-1 sialyltransferase in regulating myelopoiesis.J Biol Chem. 2010 Aug 6;285(32):25009-17. doi: 10.1074/jbc.M110.104406. Epub 2010 Jun 7. J Biol Chem. 2010. PMID: 20529847 Free PMC article.
-
The sialyltransferase ST6GAL1 protects against radiation-induced gastrointestinal damage.Glycobiology. 2020 Jul 20;30(7):446-453. doi: 10.1093/glycob/cwz108. Glycobiology. 2020. PMID: 31897489 Free PMC article.
-
Dendritic cells: a spot on sialic Acid.Front Immunol. 2013 Dec 27;4:491. doi: 10.3389/fimmu.2013.00491. Front Immunol. 2013. PMID: 24409183 Free PMC article. Review.
-
Platelets support extracellular sialylation by supplying the sugar donor substrate.J Biol Chem. 2014 Mar 28;289(13):8742-8. doi: 10.1074/jbc.C113.546713. Epub 2014 Feb 18. J Biol Chem. 2014. PMID: 24550397 Free PMC article.
-
Emerging role of alpha2,6-sialic acid as a negative regulator of galectin binding and function.J Biol Chem. 2011 Feb 25;286(8):5935-41. doi: 10.1074/jbc.R110.191429. Epub 2010 Dec 20. J Biol Chem. 2011. PMID: 21173156 Free PMC article. Review.
References
-
- Frommhold D, Ludwig A, Bixel M G, Zarbock A, Babushkina I, Weissinger M, Cauwenberghs S, Ellies L G, Marth J D, Beck-Sickinger A G, Sixt M, Lange-Sperandio B, Zernecke A, Brandt E, Weber C, Vestweber D, Ley K, Sperandio M. Sialyltransferase ST3Gal-IV controls CXCR2-mediated firm leukocyte arrest during inflammation. J Exp Med. 2008;205:1435–1446. - PMC - PubMed
-
- Priatel J J, Chui D, Hiraoka N, Simmons C J, Richardson K B, Page D M, Fukuda M, Varki N M, Marth J D. The ST3Gal-I sialyltransferase controls CD8+ T lymphocyte homeostasis by modulating O-glycan biosynthesis. Immunity. 2000;12:273–283. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
